Boston Scientific To Participate In Canaccord Genuity 2015 Medical Technology And Diagnostics Forum

MARLBOROUGH, Mass., Nov. 5, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Canaccord Genuity 9^th Annual Medical Technology and Diagnostics Forum on November 19, in New York City.

David Pierce, executive vice president & president, Endoscopy and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session regarding the company with the host analyst beginning at approximately 9:30 a.m. ET.

A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.

A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the question-and-answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

SOURCE Boston Scientific Corporation

Related Links

http://www.bostonscientific.com